Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the earnings conference call for the quarter and year ended March 31, 2022 conducted after the meeting of Board of Directors held on May 9, 2022. The above information has been uploaded on the Company''s website at https://www.suvenpharm.com/index.php/investors/financial-info/quarterly-release This is for your information and record.
13-05-2022
Bigul

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and with reference to our Results conference call intimation dated May 5, 2022, that audio recording of the conference call for the quarter and year ended March 31, 2022 held on Tuesday, May 10, 2022, has been uploaded on the Company''s website at https://www.suvenpharm.com/index.php/investors/financial-info/quarterly-release
11-05-2022

Earnings Call for Q4FY22 of Suven Pharmaceuticals

 Conference Call with Suven Pharmaceuticals Management and Analysts on Q4FY22 Performance and Outlook. Listen to the full earnings transcript.
10-05-2022
Bigul

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed the copies of the newspaper advertisements regarding to Financial Results of the Company for the quarter and year ended March 31, 2022. The advertisements as appeared today i.e. May 10, 2022 in Andhra Prabha (Telugu) and Business Standard. The above information will also be hosted on the website of the Company at: https://www.suvenpharm.com/index.php/investors/corporate-info/advertisements This is for your information and record.
10-05-2022

Suven Pharma Standalone March 2022 Net Sales at Rs 363.85 crore, up 40.39% Y-o-Y

 NULL
09-05-2022
Bigul

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Please find attached Revised Investor Presentation for 4th Quarter and Annual - FY 2022
09-05-2022
Bigul

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Please find attached investor presentation for 04th quarter and Annual - FY2022.
09-05-2022
Bigul

Suven Pharmaceuticals Ltd - 543064 - E-Annual General Meeting And Date Of Closure Of Transfer Books

 e-Annual General Meeting and Date of closure of transfer books a) The 4th e-Annual General Meeting of the members of the Company will be held on Thursday, August 18, 2022 through VC/ OAVM. b) Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, the Register of Member and Share Transfer Books of the Company will remain closed from August 16, 2022 to August 18, 2022 (both days inclusive) for the purpose of 4th Annual General Meeting of the Company.
09-05-2022
Bigul

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Date of payment of Dividend

 2. 2nd Interim Dividend a) The Board has declared 2nd Interim Dividend of Rs.1.00 per equity share (100% of Face value of Rs.1.00 each) and one-time special dividend of Rs. 1.00 per equity share (100% of Face value of Rs.1.00), totaling to Rs. 2.00 per equity share (200% of Face value of Rs. 1.00 each) for the financial year 2021-22. b) The Board has approved the Record Date i.e., 17th May, 2022 notified earlier by the Company for the purpose of payment of dividend to the eligible shareholders. c) The above said dividend will be paid on and from 25th May, 2022, subject to deduction of tax at source.
09-05-2022
Bigul

Suven Pharmaceuticals Ltd - 543064 - Corporate Action-Board approves Dividend

 2. 2nd Interim Dividend a) The Board has declared 2nd Interim Dividend of Rs.1.00 per equity share (100% of Face value of Rs.1.00 each) and one-time special dividend of Rs. 1.00 per equity share (100% of Face value of Rs.1.00), totaling to Rs. 2.00 per equity share (200% of Face value of Rs. 1.00 each) for the financial year 2021-22. b) The Board has approved the Record Date i.e., 17th May, 2022 notified earlier by the Company for the purpose of payment of dividend to the eligible shareholders. c) The above said dividend will be
09-05-2022
Next Page
Close

Let's Open Free Demat Account